MicroRNA regulation of chronic inflammation during aging

MicroRNA对衰老过程中慢性炎症的调节

• 批准号: 10531053
• 负责人: Micah J Drummond
• 金额: $ 58.8万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2027-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10531053
• 关键词: 3-Dimensional; Age; Aging; Cellular Metabolic Process; Chronic; Disease; Inflammation; Inflammatory; MicroRNAs; Molecular; Myeloid Cells; Phenotype; Regulation; T cell regulation; Work; age related; new therapeutic target; recruit; senescence

)897(*9 :DA@;5 ;@8>3??3F;A@ D787DD76 FA 3E Q;@8>3??39;@9R ;E 3 D;E= 835FAD 8AD ?3@K 397 D7>3F76 5:DA@;5 5A@6;F;A@E 7 9 6;347F7E 53@57D 8D3;>FK 47DD3@F ;??G@7 D7EBA@E7E ?3K 47 >;@=76 FA ;@8>3??3FADK ?76;3F76 ?7F34A>;5 3@6 8G@5F;A@3> 6;EAD67DE 4GF ?3@K ?75:3@;EF;5 93BE 7J;EF ?A@9 D757@F>K 3BBD75;3F76 D79G>3FADE A8 ;@8>3??39;@9 3D7 ?;5DA*'E ?;*'E (@7 7J3?B>7 A8 I:;5: ;E F:7 3@F; ;@8>3??3FADK ?;* 3 I:7D7 I7 3@6 AF:7DE :3H7 E:AI@ F:3F ?;57 678;5;7@F ;@ F:;E ?;*' EG55G?4 FA 3 >;87 E:ADF7@;@9 5:DA@;5 ;@8>3??3F;A@ F:3F ;@HA>H7E 5>;@;53>>K D7>7H3@F 5A?AD4;6;F;7E &AD7AH7D 67>7F;A@ A8 ?;* ;@ , 57>>E E;9@;8;53@F>K 7JF7@6E F:7 >;87EB3@ A8 ?;* 3 ?;57 I:;5: BA;@FE FA 3 H;F3> DA>7 8AD , 57>> 7JBD7EE76 ?;* ;@ F:;E 5A@F7JF ;@5>G6;@9 , 8A>>;5G>3D :7>B7D ,8: 57>>E /7 :3H7 D757@F>K 7JB3@676 AGD 3@3>KE7E A8 F:;E 5D;F;53> BDA57EE 4K ;@H7EF;93F;@9 @AH7> B3F:I3KE ;@ 39;@9 , 57>>E F:3F 3D7 D79G>3F76 4K ?;* 6GD;@9 ;@8>3??39;@9 K 5A@6G5F;@9 E;@9>7 57>> *' +7CG7@5;@9 E5*' +7C I7 :3H7 ;67@F;8;76 F:D77 97@7 BDA9D3?E F:3F 3D7 5AG@F7D D79G>3F76 4K ?;* 3 3@6 ?;* ;@ 3976 , 57>>E F:3F :3H7 @AF 477@ BD7H;AGE>K 7J3?;@76 ;@ F:;E 5A@F7JF ,:7E7 ;@5>G67 37DA4;5 9>K5A>KE;E 5:7?A=;@7 BDA6G5F;A@ 3@6 E7@7E57@57 3EEA5;3F76 E75D7FADK B:7@AFKB7 ++) 835FADE 66;F;A@3> BD7>;?;@3DK 63F3 EF7??;@9 8DA? ;@;F;3> 7JB>AD3F;A@ A8 F:7E7 B3F:I3KE :3H7 BA;@F76 GE FA 3 @AH7> 397 3EEA5;3F76 ;@8>3??3FADK , 57>> EG4E7F ,33 57>>E F:3F ;E 2&$ 3@6 F:3F 7JB3@6E ;@ 4AF: ?;57 3@6 :G?3@E 3@6 F:3F ;E D79G>3F76 4K ?;* 3E76 A@ F:7E7 BD7>;?;@3DK 63F3 I7 I;>> 53DDK AGF F:7 8A>>AI;@9 D7E73D5: 3;?E ;@ 3@ 788ADF FA 93;@ EG4EF3@F;3> @7I ;@E;9:FE ;@FA , 57>> 67B7@67@F ?75:3@;E?E F:3F 6D;H7 ;@8>3??39;@9 3@6 F:3F 3D7 D79G>3F76 4K ?;*'E /7 I;>> 3>EA G@;CG7>K 7JF7@6 F:7E7 3@3>KE7E FA KAG@9 3@6 A>67D 36G>FE ;@ 788ADFE FA FD3@E>3F7 AGD 8;@6;@9E FA :G?3@E ,9,7304, 9/, -:4*9054(2 752,8 5- 30# 04+:*,+ ' % *,228 +:704. 04-2(33(.04. ,9,7304, 9/, 352,*:2(7 (4+ 3,9()520* 3,*/(40838 :4+,72>04. 30# -:4*90548 04 % *,228 +:704. 04-2(33(.04. ,9,7304, 0- %(( (4+ %-/ *,228 (4+ 9/,07 30# 2,;,28 04 52+,7 (+:298 *577,2(9, <09/ 3(71,78 5- */7540* 25< .7(+, 04-2(33(9054 048:204 8,48090;09> (4+ 3:8*2, 897,4.9/ /7 3@F;5;B3F7 F:3F F:;E IAD= I;>> G@H7;> =7K 57>>G>3D 3@6 ?A>75G>3D ?75:3@;E?E 4K I:;5: ?;*'E B>3K B;HAF3> DA>7E ;@ D79G>3F;@9 >;87EB3@ F:DAG9: F:7;D ;@8>G7@57 A@ , 57>> ?76;3F76 397 67B7@67@F 5:DA@;5 ;@8>3??3F;A@ E 3 D7EG>F F:7D3B7GF;53>>K 35F;A@34>7 F3D97FE I;>> 7?7D97 I;F: F:7 BAF7@F;3> FA >;?;F 397 3EEA5;3F76 :G?3@ ;@8>3??3FADK 6;E73E7E F:3F 5A@F;@G7 FA D3B;6>K 93;@ ;@ BD7H3>7@57 ;@ AGD EA5;7FK

) 897 (* 9